Ultra Squared Ventures - Company finances
|
EUR
|
2023
From: 2023-05-05
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 42,000 | 20,750 | 60,440 |
| Profit before tax | 36,444 | 68,822 | -11,776 |
| Net profit | 36,444 | 65,373 | -11,776 |
| Equity | 1,547 | 66,622 | 54,846 |
| Liabilities | 2,554 | 3,996 | 3,741 |
| Non-current assets | 300 | 1,054 | 2,535 |
| Current assets | 3,801 | 69,564 | 56,052 |
| Total assets | 4,101 | 70,618 | 58,587 |
|
Taxes paid
|
|||
| STI taxes | - | 3,308 | 9,892 |
|
Financial indicators
|
|||
| Revenue change y/y | - | -50.6% | +191.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 888.7% | 92.6% | -20.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 2355.8% | 98.1% | -21.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 86.8% | 315.1% | -19.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 86.8% | 331.7% | -19.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.7 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ultra Squared Ventures - Social security debts
The company had no debts to Sodra
Ultra Squared Ventures - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-04-22 | 2.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ultra Squared Ventures, MB (code 306311954) is a Small partnership engaged in research and experimental development on other natural sciences and engineering. In 2025, the company generated revenue of €60.4K, up 191.3% year on year and 43.9% over two years. Despite the stronger turnover, it reported a net loss of €11.8K, compared with a profit of €65.4K in 2024 and €36.4K in 2023. The 2024 result was exceptionally strong, while 2025 marked a return to negative profitability. Over the three-year period, revenue moved from €42.0K in 2023 to €20.8K in 2024 and then to €60.4K in 2025. At the end of 2025, total assets stood at €58.6K, equity at €54.8K and liabilities at €3.7K, indicating a very strong equity position. Long-term assets were €2.5K and short-term assets €56.1K. Key 2025 ratios show a negative return on equity of -21.5%, return on assets of -20.1%, debt-to-equity of 0.07, and asset turnover of 1.03x.